Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/91157
Title: Enhanced solid-state stability of amorphous ibrutinib formulations prepared by hot-melt extrusion
Authors: Simões, Marta F.
Nogueira, Bernardo A. 
Tabanez, Andreia M. 
Rui Fausto 
Pinto, Rui M. A. 
Simões, Sérgio
Keywords: Amorphous solid dispersions; Hot-melt extrusion; Ibrutinib; Multivariate statistics; Polymers; Principal components analysis
Issue Date: 16-Feb-2020
Publisher: Elsevier
Project: info:eu-repo/grantAgreement/FCT/PD/BDE/135149/2017/PT 
info:eu-repo/grantAgreement/FCT/UI0313/QUI/2013/PT 
Serial title, monograph or event: International Journal of Pharmaceutics
Volume: 579
Abstract: One of the applications of Hot-Melt Extrusion (HME) is the stabilization of amorphous drugs through its incorporation into polymeric blends in the form of Amorphous Solid Dispersions (ASDs). In this study, HME was applied to solve a real problem in the development of an ibrutinib product, stabilizing the amorphous form. A systematic approach was followed by combining theoretical calculations, high-throughput screening (HTS) focused on physical stability and Principal Components Analysis (PCA). The HTS enabled the evaluation of 33 formulations for physical stability and the PCA was key to select four promising systems. The low relevance of drug loading on the drug crystallization supported the HME tests with a very high drug load of 50%. Milled extrudates were characterized and demonstrated to be fully amorphous. The thermal analysis detected a glass transition temperature much higher than the predicted values. Along with several weak intermolecular interactions detected in Raman spectroscopy, a dipolar interaction involving the α, β unsaturated ketone function of ibrutinib was also noticed. The additive effect of these intermolecular interactions changed markedly the performance of the ASDs. The physical strength of the prepared systems was corroborated by stability studies until 6 months at long-term and accelerated conditions.
URI: https://hdl.handle.net/10316/91157
ISSN: 03785173
DOI: 10.1016/j.ijpharm.2020.119156
Rights: embargoedAccess
Appears in Collections:I&D CQC - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
Intl_J_Pharmaceut_579_2020_119156.pdf1.88 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

24
checked on Mar 18, 2024

WEB OF SCIENCETM
Citations

20
checked on Mar 2, 2024

Page view(s)

153
checked on Mar 26, 2024

Download(s)

320
checked on Mar 26, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons